DreaMed Diabetes, an Israeli-based developer of personalized diabetes management solutions, today announced that the U.S Food and Drug Administration (FDA) has granted a De Novo request for DreaMed Advisor Pro, an artificial intelligence (AI)-based diabetes treatment decision support software. Advisor Pro is indicated to assist healthcare providers in the management of people with type 1 diabetes who use insulin pumps and continuous glucose monitoring (CGM).The announcement marks the second
Read More
Impact of Precision Medicine| News, Policy, Analysis, Insights - HIT Consultant
Syapse Precision Medicine Council Launches to Advance Precision Oncology Adoption
Syapse, a San Francisco, CA-based precision medicine company, announced today the formation of the Syapse Precision Medicine Council, a group of oncology, operations, and research leaders from health systems dedicated to advancing precision oncology adoption through sharing best practices.Inaugural members include Henry Ford Health System, Catholic Health Initiatives and Dignity Health (the Precision Medicine Alliance), Providence St. Joseph Health, Aurora Health Care, and the University of
Read More
5 Ways SmartTrials is Advancing Precision Medicine Through Genomics
Foundation Medicine’s Dr. Gaurav Singal shares how his company’s platform is changing the game in clinical trials and bolstering precision medicine through genomics.The evolution may be slow going, but it looks like precision medicine is destined to disrupt many aspects of healthcare, and it’s already demonstrating that transformative power in clinical trials—where patient recruitment and retention have long plagued the process, according to Foundation Medicine’s Dr. Gaurav Singal.“Current
Read More
Fitango Health Unveils Oncology Precision Medicine App for Providers to Achieve Value-Based Goals
Fitango Health, a provider of integrated care management and patient engagement software, is announcing a transformative new solution, called Fitango Oncology. Fitango Health's innovative application allows healthcare providers to achieve value-based goals through end-to-end engagement spanning the continuum of care.This end-to-end solution is the first of its kind for both oncology and chronic care to integrate decision-support, treatment communication, along with enabling and engaging both
Read More
2bPrecise and PierianDx Team Up to Offer Precision Medicine Solution for Providers
2bPrecise, an EHR-agnostic, cloud-based precision medicine platform, today announced it is collaborating with PierianDx, Inc., the leading clinical genomics knowledge base company, to offer a comprehensive precision medicine solution. The combined solution brings together genomic and clinical data to help providers make more informed care decisions for their patients. This unique technology enables clinicians to concentrate on the most important information to determine what is best for each
Read More
Aspire, LG Health Launches $300M Precision Medicine Fund for Personalized Devices
Aspire Universal, a private equity firm and venture company today announced the establishment of the $300M Aspire Ventures Precision Medicine Fund (AVP) to accelerate innovation for personalized devices and medical practices. Precision medicine is one of the most important transformations ever to come to medicine, and by shifting away from one-size-fits-all solutions, precision medicine offers personalized solutions that deliver better experiences and better outcomes at a lower cost. The AVP
Read More
Mount Sinai Taps Joel Dudley, PhD to Create Precision Health Enterprise
Joel Dudley, PhD, an internationally recognized investigator in translational bioinformatics and precision medicine, has been named Executive Vice President for Precision Health for the Mount Sinai Health System. In this new role, he will create a Precision Health Enterprise by linking pioneering research conducted in the Icahn School of Medicine at Mount Sinai (ISMMS) with implementation strategies developed in collaboration with leadership and staff throughout the Health System.Precision
Read More
Boston Children’s Hospital Powers Pediatric Patients with Virtual Reality to Visualize Their Insides
Boston Children’s Hospital and Klick Health, today unveiled a virtual reality (VR) platform to bring patients’ individual medical findings to life in an immersive, 3D environment. The proof of concept VR platform named HealthVoyager is a medical education and patient experience platform. The first iteration of the tool, HealthVoyager™ GI, has been designed for pediatric gastrointestinal (GI) patients and is being used at Boston Children’s as part of a clinical study to validate its effect on
Read More
Cota Lands $40M to Accelerate Value-based Precision Medicine
Cota, a NYC-based healthcare data and analytics company bridging precision medicine to population health has raised $40 million in Series C funding led by QVIA and was contributed to by EW Healthcare Partners. Memorial Sloan Kettering Cancer Center also participated in the round, along with existing Cota investors which include, Boston Millennia Partners, Horizon Blue Cross Blue Shield of New Jersey, Hackensack Meridian Health and Atoc Holdings.The funding will go towards rapidly scaling its
Read More
Cedars-Sinai, Emulate Partner on ‘Patient-on-a-Chip’ Program to Predict Disease Treatments
Scientists at Cedars-Sinai and Boston-based digital health startup Emulate are pioneering a Patient-on-a-Chip program to help predict which disease treatments would be most effective based on a patient's genetic makeup and disease variant—a new approach to advance precision medicine.Researchers know that people respond differently to foods, drugs, and chemicals. For example, a medication may be effective in one individual, while it makes another even more ill. Until now, we’ve had no way to test
Read More
